Leupeptin Ac-LL

• Description :

  Leupeptin Ac-LL is a protease inhibitor from actinomycetes. Leupeptin Ac-LL has antiplasmin activity[1].

• UNSPSC :

  12352209

• Hazard Statement :

  H302-H315-H319-H335

• Target :

  Ser/Thr Protease

• Type :

  Reference compound

• Related Pathways :

  Metabolic Enzyme/Protease

• Applications :

  Metabolism-protein/nucleotide metabolism

• Field of Research :

  Cancer; Metabolic Disease; Inflammation/Immunology

• Assay Protocol :

  https://www.medchemexpress.com/leupeptin-ac-ll.html

• Solubility :

  10 mM in DMSO

• Smiles :

  CC(C)C[C@H](NC(C)=O)C(N[C@@H](CC(C)C)C(NC(C=O)CCCNC(N)=N)=O)=O

• Molecular Formula :

  C20H38N6O4

• Molecular Weight :

  426.55

• Precautions :

  P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501

• References & Citations :

  [1]T Aoyagi, et al. Leupeptins, new protease inhibitors from Actinomycetes. J Antibiot (Tokyo) . 1969 Jun;22 (6) :283-6. |[2]K Maeda, et al. The structure and activity of leupeptins and related analogs. J Antibiot (Tokyo) . 1971 Jun;24 (6) :402-4.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [24365-47-7]